High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival.

MLA

Baongoc Nasri, et al. “High Expression of EphA3 (Erythropoietin-Producing Hepatocellular A3) in Gastric Cancer Is Associated with Metastasis and Poor Survival.” BMC Clinical Pathology, vol. 17, Apr. 2017, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12907-017-0047-y.

APA

Baongoc Nasri, Mikito Inokuchi, Toshiaki Ishikawa, Hiroyuki Uetake, Yoko Takagi, Sho Otsuki, Kazuyuki Kojima, & Tatsuyuki Kawano. (2017). High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival. BMC Clinical Pathology, 17, 1–7. https://doi.org/10.1186/s12907-017-0047-y

Chicago

Baongoc Nasri, Mikito Inokuchi, Toshiaki Ishikawa, Hiroyuki Uetake, Yoko Takagi, Sho Otsuki, Kazuyuki Kojima, and Tatsuyuki Kawano. 2017. “High Expression of EphA3 (Erythropoietin-Producing Hepatocellular A3) in Gastric Cancer Is Associated with Metastasis and Poor Survival.” BMC Clinical Pathology 17 (April): 1–7. doi:10.1186/s12907-017-0047-y.